Seeing Is Believing
Currently out of the existing stock ratings of Eric Joseph, 120 are a BUY (57.42%), 71 are a HOLD (33.97%), 18 are a SELL (8.61%).
Analyst Eric Joseph, currently employed at JPMORGAN, carries an average stock price target met ratio of 57.49% that have a potential upside of 42.54% achieved within 134 days.
Eric Joseph’s has documented 401 price targets and ratings displayed on 45 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on KYMR, Kymera Therapeutics at 03-Jun-2025.
Analyst best performing recommendations are on MNTA (MOMENTA PHARMACEUTICALS).
The best stock recommendation documented was for MNTA (MOMENTA PHARMACEUTICALS) at 1/14/2020. The price target of $30 was fulfilled within 2 days with a profit of $4.64 (18.3%) receiving and performance score of 91.48.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$7.5
$3.82 (103.80%)
$7.5
2 months 23 days ago
(04-Apr-2025)
14/29 (48.28%)
$5.73 (323.73%)
327
Buy
$4
$0.32 (8.70%)
$2
2 years 27 days ago
(31-May-2023)
1/12 (8.33%)
$2.96 (284.62%)
721
Buy
$1
$-1.14 (-53.27%)
$8
3 years 2 months 26 days ago
(01-Apr-2022)
1/2 (50%)
$0.33 (49.25%)
311
Hold
$2
$-1.68 (-45.65%)
$6
3 years 2 months 27 days ago
(31-Mar-2022)
3/11 (27.27%)
$1.28 (177.78%)
467
Buy
$6
3 years 2 months 27 days ago
(31-Mar-2022)
0/3 (0%)
$3.28 (120.59%)
Which stock is Eric Joseph is most bullish on?
Which stock is Eric Joseph is most reserved on?
What Year was the first public recommendation made by Eric Joseph?